Ponoi Capital II, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 65,238 shares at $12.90 ($842K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
Open-market purchase of $842k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.90 | 1,094 | $14K | 1.7% |
| 2 | $12.90 | 32,072 | $414K | 49.2% |
| 3 | $12.90 | 32,072 | $414K | 49.2% |
| Total | $12.90 avg | 65,238 | $842K | 100% |
| Filing → |
| NGM | BUY | 2022-10-27 | $1.2M | — | Filing → |
| RAPT | SELL | 2021-09-29 | $578K | — | Filing → |
| NGM | BUY | 2020-03-25 | $7.1M | — | Filing → |